← SynDRA
SCH-202676
SynDRA canonical compound SYN0087413 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | DRD2 |
|---|
| Mechanism of action | G protein-coupled receptor modulator |
|---|
All known targets
- CHRM1
- CHRM2
- DRD1
- DRD2
- CHRM4
Mechanisms of action (all sources)
- G protein-coupled receptor modulator
Cross-references
Synonyms
- N-methyl-2,3-diphenyl-1,2,4-thiadiazol-5-imine
- MLS002153327
- SMR001230740
- N-methyl-2,3-diphenyl-1,2,4-thiadiazol-5-imine;hydrobromide
- Lopac-S-4063
- Lopac0_001078
- Oprea1_002944
- orb1702823
- SCHEMBL12305077
- SCHEMBL15521903
- SCHEMBL15521904
- BDBM60981
- cid_11957689
- BDBM350103
- AKOS040746332
- CCG-205155
- SDCCGSBI-0051048.P002
- NCGC00015951-01
- NCGC00015951-02
- NCGC00015951-03
- NCGC00015951-08
- NCGC00015951-11
- NCGC00162335-01
- NCGC00162335-02
- NCGC00162335-03
- DA-67478
- MS-33121
- PD054318
- HY-133862
- CS-0134420
- T24770
- US10208043, # 4
- US10941146, # 4
- BRD-K29562203-004-02-6
- BRD-K29562203-004-08-3
- N-Methyl-2,3-diphenyl-1,2,4-thiadiazol-5(2H)-imine
- N-(2,3-diphenyl-[1,2,4]thiadiazole-5(2h)-ylidene)methanamine
- SCH-202676 (hydrobromide)
- orb3137024
Look up SCH-202676 in the interactive SynDRA portal →